ANTIBODIES TO IL-6 AND USE THEREOF

The present invention is directed to therapeutic methods using IL-6 antagonists such as an Ab1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof. In preferred embodiments these pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Carvalho Jensen, Anne Elisabeth, Dutzar, Benjamin H, Kovacevich, Brian R, Anderson, Katie Olson, Litton, Mark, Smith, Jeffrey T.L, Latham, John A, Garcia-Martinez, Leon F, Schatzman, Randall C
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Carvalho Jensen, Anne Elisabeth
Dutzar, Benjamin H
Kovacevich, Brian R
Anderson, Katie Olson
Litton, Mark
Smith, Jeffrey T.L
Latham, John A
Garcia-Martinez, Leon F
Schatzman, Randall C
description The present invention is directed to therapeutic methods using IL-6 antagonists such as an Ab1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019083665A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019083665A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019083665A13</originalsourceid><addsrcrecordid>eNrjZFBy9AvxdPJ38XQNVgjxV_D00TVTcPRzUQgNdlUI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGlgYWxmZmpo6GxsSpAgCQeSL3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODIES TO IL-6 AND USE THEREOF</title><source>esp@cenet</source><creator>Carvalho Jensen, Anne Elisabeth ; Dutzar, Benjamin H ; Kovacevich, Brian R ; Anderson, Katie Olson ; Litton, Mark ; Smith, Jeffrey T.L ; Latham, John A ; Garcia-Martinez, Leon F ; Schatzman, Randall C</creator><creatorcontrib>Carvalho Jensen, Anne Elisabeth ; Dutzar, Benjamin H ; Kovacevich, Brian R ; Anderson, Katie Olson ; Litton, Mark ; Smith, Jeffrey T.L ; Latham, John A ; Garcia-Martinez, Leon F ; Schatzman, Randall C</creatorcontrib><description>The present invention is directed to therapeutic methods using IL-6 antagonists such as an Ab1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others.</description><language>eng</language><subject>CHEMISTRY ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE ; TESTING</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190321&amp;DB=EPODOC&amp;CC=US&amp;NR=2019083665A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190321&amp;DB=EPODOC&amp;CC=US&amp;NR=2019083665A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Carvalho Jensen, Anne Elisabeth</creatorcontrib><creatorcontrib>Dutzar, Benjamin H</creatorcontrib><creatorcontrib>Kovacevich, Brian R</creatorcontrib><creatorcontrib>Anderson, Katie Olson</creatorcontrib><creatorcontrib>Litton, Mark</creatorcontrib><creatorcontrib>Smith, Jeffrey T.L</creatorcontrib><creatorcontrib>Latham, John A</creatorcontrib><creatorcontrib>Garcia-Martinez, Leon F</creatorcontrib><creatorcontrib>Schatzman, Randall C</creatorcontrib><title>ANTIBODIES TO IL-6 AND USE THEREOF</title><description>The present invention is directed to therapeutic methods using IL-6 antagonists such as an Ab1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others.</description><subject>CHEMISTRY</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBy9AvxdPJ38XQNVgjxV_D00TVTcPRzUQgNdlUI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGlgYWxmZmpo6GxsSpAgCQeSL3</recordid><startdate>20190321</startdate><enddate>20190321</enddate><creator>Carvalho Jensen, Anne Elisabeth</creator><creator>Dutzar, Benjamin H</creator><creator>Kovacevich, Brian R</creator><creator>Anderson, Katie Olson</creator><creator>Litton, Mark</creator><creator>Smith, Jeffrey T.L</creator><creator>Latham, John A</creator><creator>Garcia-Martinez, Leon F</creator><creator>Schatzman, Randall C</creator><scope>EVB</scope></search><sort><creationdate>20190321</creationdate><title>ANTIBODIES TO IL-6 AND USE THEREOF</title><author>Carvalho Jensen, Anne Elisabeth ; Dutzar, Benjamin H ; Kovacevich, Brian R ; Anderson, Katie Olson ; Litton, Mark ; Smith, Jeffrey T.L ; Latham, John A ; Garcia-Martinez, Leon F ; Schatzman, Randall C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019083665A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>Carvalho Jensen, Anne Elisabeth</creatorcontrib><creatorcontrib>Dutzar, Benjamin H</creatorcontrib><creatorcontrib>Kovacevich, Brian R</creatorcontrib><creatorcontrib>Anderson, Katie Olson</creatorcontrib><creatorcontrib>Litton, Mark</creatorcontrib><creatorcontrib>Smith, Jeffrey T.L</creatorcontrib><creatorcontrib>Latham, John A</creatorcontrib><creatorcontrib>Garcia-Martinez, Leon F</creatorcontrib><creatorcontrib>Schatzman, Randall C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Carvalho Jensen, Anne Elisabeth</au><au>Dutzar, Benjamin H</au><au>Kovacevich, Brian R</au><au>Anderson, Katie Olson</au><au>Litton, Mark</au><au>Smith, Jeffrey T.L</au><au>Latham, John A</au><au>Garcia-Martinez, Leon F</au><au>Schatzman, Randall C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODIES TO IL-6 AND USE THEREOF</title><date>2019-03-21</date><risdate>2019</risdate><abstract>The present invention is directed to therapeutic methods using IL-6 antagonists such as an Ab1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2019083665A1
source esp@cenet
subjects CHEMISTRY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
TESTING
title ANTIBODIES TO IL-6 AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A46%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Carvalho%20Jensen,%20Anne%20Elisabeth&rft.date=2019-03-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019083665A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true